Manufacturer record
Amkon Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
8 batches manufactured by Amkon Pharmaceuticals (Punjab) were declared Not of Standard Quality between November 2021 and November 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: APT/04591, Sensikast-LC Tablets (Levocetirizine Hydrochloride & Montelukast Sodium Tablets) (exp May 2023). RDTL Guwahati (state lab) found it not of standard quality: Identification and Assay/Content of Levocetirizine Dihydrochlorid e and Montelukast. Listed in the November 2022 alert.
Records by type
8 records linked to Amkon Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Sensikast-LC Tablets (Levocetirizine Hydrochloride & Montelukast Sodium Tablets) | Batch APT/04591Mfg Jun 2021 · Exp May 2023 | Identification and Assay/Content of Levocetirizine Dihydrochlorid e and MontelukastAssay | RDTL GuwahatiState lab | Nov 2022 |
| Diclopac (Diclofenac Potassium and Paracetamol Tablets) | Batch APT/04682Mfg Jul 2021 · Exp Jun 2023 | AssayAssay | CDL KolkataCDSCO lab | Nov 2022 |
| Oflopac-OZ Tablet (Ofloxacin & Ornidazole Tablet I.P.) | Batch APNT/206Mfg Apr 2022 · Exp Mar 2024 | Identification & AssayAssay | CDL KolkataCDSCO lab | Aug 2022 |
| Metfovan -500 SR Tablets (Metformin Hydrochloride (SR) Tablets) | Batch APT/04215Mfg Mar 2021 · Exp Feb 2023 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | May 2022 |
| Levetripac-500 Tablets (Levetiracetam Tablets IP 500 mg) | Batch APT/04306Mfg Apr 2021 · Exp Mar 2023 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Jan 2022 |
| ZINCOPAC BOOST Tablets (Zinc Acetate Tablets 50 mg) | Batch APT/04418Mfg May 2021 · Exp Apr 2023 | Assay of Elemental ZincAssay | CDL KolkataCDSCO lab | Dec 2021 |
| Telmopac ? AM (Telmisartan & Amlodipine Tablets) | Batch APT/04282Mfg Apr 2021 · Exp Mar 2023 | Dissolutoin, Related Substances and AssayAssay | CDL KolkataCDSCO lab | Nov 2021 |
| Oflopac ? OZ Tablet (Ofloxacin & Ornidazole Tablets I.P.) | Batch APT/03047Mfg Apr 2020 · Exp Mar 2022 | Identification of Ofloxacin, and Dissolution & Assay of Ofloxacin & OrnidazoleAssay | CDL KolkataCDSCO lab | Nov 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.